American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategi... (

American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance

Date:4/15/2008

- Joint Effort to Capitalize on China's Narcotic and Pain-Management Market

Opportunity -

NEW YORK, April 15 /PRNewswire-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), a leading marketer, distributor and manufacturer of pharmaceutical and healthcare products in China, and China Aoxing Pharmaceutical Company, Inc. (OTC Bulletin Board: CAXG) ("China Aoxing"), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that they have formed a strategic alliance to jointly commercialize and develop narcotic and pain-management products in China. As part of this alliance, American Oriental Bioengineering will make an equity investment of $18.0 million in China Aoxing.

The size of the narcotic and pain-management market in China is estimated to be roughly US$300 million today, highly underdeveloped versus Western countries, and growing at an estimated compound annual growth rate of 23 percent.(1) China Aoxing is one of only a few manufacturers designated by the China State Food & Drug Administration (SFDA) to operate in the highly regulated narcotics industry.

Under the terms of the agreement, American Oriental Bioengineering makes an equity investment of $18.0 million in exchange for 30 million shares of newly-issued China Aoxing common stock, priced at US$0.60 per share, and owns approximately 38% of China Aoxing. Additionally, with today's announcement, China Aoxing closed its previously announced acquisition of Shijiazhuang Lerentang Pharmaceutical Company Ltd. ("LRT"), a China-based pharmaceutical company focused on pain-management products.

China Aoxing and Amer
'/>"/>

SOURCE American Oriental Bioengineering, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4
Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
3. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
4. American Oriental Bioengineering Announces Participation in September Investor Conferences
5. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
6. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
7. Tips from the Journals of the American Society for Microbiology
8. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
9. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
10. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
11. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance

Post Your Comments:

(Date:12/11/2009)... -- EntreMed, Inc. (Nasdaq: ENMD ), today ... revenue from sales of Thalomid® during the third ... million. In addition, the Company anticipates a ... fiscal 2009. The difference in estimated and ... reflected in the fourth quarter financial results. ,, ...

(Date:12/11/2009)... December 2009 -- Researchers have discovered a new explanation for ... more excess copies of a certain gene, the more serious ... and it is suspected that it is the amount of ... are being published in the American Journal of Human ... group of Guy Froyen connected to VIB, a life sciences ...

(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer therapeutics company, ... the,US, the Tulane Cancer Center, New Orleans, ... clinical study of Alpharadin in men with,castration-resistant ... has metastasized to the skeleton. , ... SYMptomatic Prostate CAncer) study is a,double-blind, randomized, ...

(Date:12/11/2009)... Inc. (TSX:ONC, NASDAQ: ONCY ) ("Oncolytics" or the ... Warrander to the role of Senior Vice President, ... will be responsible for the execution of the ... Thompson, President and CEO of Oncolytics. "Having reached ... 3 trial examining REOLYSIN in combination with paclitaxel ...

Breaking Biology Technology:EntreMed Reports Receipt of Third Quarter Royalty Payment 2 Amount of gene surplus determines severity of mental retardation in males 2 Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2 Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3 Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4 Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2 Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3

[0] EntreMed Reports Receipt of Third Quarter Royalty Payment [0] Amount of gene surplus determines severity of mental retardation in males [0] Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans [0] Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development

... Medical College of Wisconsin has implemented IBM s ... infrastructure support system for proteomics research. IBM announced last month ... on Power Architecture will begin shipping in volume globally ... site to test the Sequest application on the JS20 running ...

... MADISON Advances in the development of healthcare ... electronic healthcare. Although the technology exists, organizations often ... systems to a more efficient and safer digital ... Leveraging Information Technology to Improve Patient Safety and ...

... Now that Gov. Jim Doyle has signed a bill ... states technology sector blossom like a spring flower? , ,Based ... creation of tax credits for angel and early-stage investments as ... news, but its only one step toward easing Wisconsins chronic ...

Other Biology Technology:Medical College of Wisconsin enhances research with IBM Blade server 2 UW symposium to explore impact of IT on improving quality, safety and cost of healthcare 2 Investment tax credit bill is a good start, but Wisconsin must confront other barriers to capital formation 2 Investment tax credit bill is a good start, but Wisconsin must confront other barriers to capital formation 3

Medical College of Wisconsin enhances research with IBM Blade server UW symposium to explore impact of IT on improving quality, safety and cost of healthcare Investment tax credit bill is a good start, but Wisconsin must confront other barriers to capital formation

(Date:12/11/2009)... Ivy Pike, an associate professor of anthropology at the ... rural northern Kenya to understand how violence shapes the ... The results of her and her colleagues, research," Documenting ... communities of northern Kenya: A conceptual framework," is currently ... and Medicine , in collaboration with the British medical ...

(Date:12/11/2009)... Keystone Symposia on Molecular and Cellular Biology is ... Keystone Symposia Fellows for 2010. Launched in 2008, ... scientists (postdoctoral trainees or assistant professors) to shadow ... year. Fellows are selected based on their research ... diversity in the biomedical and life sciences. As ...

(Date:12/11/2009)... available in German . , ... plant introductions than extinctions, plant communities of many ... species are occurring more frequently, whereas rare species ... biological communities that are becoming increasingly similar, but ... have led to a loss of uniqueness among ...

[0] UA-led study grapples with health effects of low-intensity warfare [0] Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative [0] Europe's flora is becoming impoverished

... (9-14-07) Oxidative stress is known to underlie many ... A team of scientists from Boston College has found ... stress plays in the development of diseases by studying ... the oxidative stress response has come primarily from studies ...

... system police are as good at recognizing bad guys, such ... researchers say. , The finding may cause a stir in ... cells or Tregs, preferentially respond to body proteins, or self ... bacteria. , Now, Medical College of Georgia immunologists report ...

... the 2007 American Society for Microbiology (ASM) ICAAC ... Inc., U.S. Human Health, will be presented to ... Child Health and Human Development (NICHD), Bethesda, Maryland. ... research excellence in microbiology and infectious disease. ...

Other Biology News:Boston College profs study oxidative stress subcellular to discover its role in diseases 2 Immune police recognize good and bad guys in the body 2 Immune police recognize good and bad guys in the body 3

Boston College profs study oxidative stress subcellular to discover its role in diseases Immune police recognize good and bad guys in the body American Society for Microbiology honors Joanna Kubler-Kielb

D4-GDI rabbit polyclonal antibody...

Mouse monoclonal [SPM217] to Secretory Component Glycoprotein ( Abpromise for all tested applications)....

Rabbit polyclonal to FLIP ( Abpromise for all tested applications). entrezGeneID: 8837 SwissProtID: O15519...

... [EP282Y] to Asparagine synthetase ( ... applications). Antigen: ... residues in the C-terminus of ... Entrez GeneID: 440 ...

Biology Products:

Rabbit Anti-D4-GDI Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents Mouse Anti-Secretory Component Glycoprotein Monoclonal Antibody, Unconjugated, Clone SPM217 from Abcam Rabbit Anti-FLIP Polyclonal Antibody, Unconjugated from Abcam Rabbit Anti-Asparagine synthetase Monoclonal Antibody, Unconjugated, Clone EP282Y from Abcam

American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategi...( - Joint Effort to Capitalize on China...)